Federal contractor · LEXINGTON, KY

MURTY PHARMACEUTICALS, INC.

MURTY PHARMACEUTICALS, INC. received $92.7K in federal contract obligations in FY2026, on 1 awards (0% vs FY2025). Since FY2017: $2.5M. Its largest customer was National Institutes of Health ($92.7K).

Obligations · FY2026
$92.7K
New awards
1
Sole-source
0.0%
Single offer
0.0%
UEI
DNJBTJ3XBQM6
Small businessMinority-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 777.9KFY2017
  2. 308.2KFY2018
  3. 460.3KFY2019
  4. 97.6KFY2020
  5. 871.7KFY2021
  6. -129.2KFY2022
  7. -11.9KFY2023
  8. -101.9KFY2024
  9. 92.7KFY2025
  10. 92.7KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$92.7K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$92.7K100%

Where the work was performed

  1. Fayette County, KY$92.7K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. FY26. TO 7 - DRUG PRODUCT STABILITY STUDIES. POP 9/13/26-9/12/27.$92.7K
    National Institutes of Health· Fayette County, KY· Research & development· Aug 25, 2026 – Aug 25, 2026· 75N98026F00001

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. MAKERERE UNIVERSITY CENTRE FOR HEALTH & POPULATION RESEARCH$82.7K
    KAMPALA, UGA · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. BIOSKRYB GENOMICS, INC.$77.8K−41% in FY2026
    DURHAM, NC · 93% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. CELL SIGNALING TECHNOLOGY, INC.$90K−100% in FY2026
    DANVERS, MA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.